ER Editor: The former French health minister, interviewed below at the end of May on France’s CNN equivalent, BFMTV (although it isn’t quite as bad as CNN), Philippe Douste-Blazy, is a former cardiologist and seasoned minister through several French governments. He is regarded as a reliable source in France.
We recommend following on Twitter Dr. James Todaro, who revealed this interview. Dr. Todaro runs the website MedicineUncensored. Regarding the hatchet job medical data/education company Surgisphere did on hydroxychloroquine by providing a large amount of data from various medical facilities around the world (which turned out to be suspect), we recommend this Guardian piece from a week ago titled Surgisphere: governments and WHO changed Covid-19 policy based on suspect data from tiny US company. Their flawed data managed to influence studies and information put out by The Lancet and The New England Journal of Medicine. It would seem that The Lancet was used as a data-laundering front to provide respectability, which then managed to influence the WHO’s policy recommendations globally regarding hydroxy use for COVID-19. See Dr. Todaro’s article from his site, titled A Study Out of Thin Air.
It’s curious how professionally-flawed individuals like Surgisphere’s Sapan Desai, a former vascular surgeon with a shady past, and Professor Neil ‘Lockdown’ Ferguson manage to wield so much power over major health organizations, who then arbitrate against affordable, effective treatments and/or pharmaceuticals such as hydroxychloroquine.
We’ve inserted the short, English-subtitled video below; here is the link to the longer 10-minute interview which is, alas, not subtitled.
Big Pharma “Criminal” Influence On Research Exposed In Secret Recording Of Lancet And NEJM Editors-In-Chief
A secretly recorded meeting between the editors-in-chief of The Lancet and the New England Journal of Medicine reveal both men bemoaning the “criminal” influence big pharma has on scientific research.
According to Philippe Douste-Blazy, France’s former Health Minister and 2017 candidate for WHO Director, the leaked 2020 Chatham House closed-door discussion between the EIC’s (ER: editor-in-chiefs) – whose publications both retracted papers favorable to big pharma over fraudulent data:
“Now we are not going to be able to, basically, if this continues, publish any more clinical research data because the pharmaceutical companies are so financially powerful today, and are able to use such methodologies, as to have us accept papers which are apparently methodologically perfect, but which, in reality, manage to conclude what they want them to conclude,” said Lancet EIC Dr. Richard Horton.
According to Douste-Blazy, the EICs said the influence wielded by Big Pharma to influence publications is “criminal.”